Corporate presentation
Logotype for Telescope Innovations Corp

Telescope Innovations (TELI) Corporate presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Telescope Innovations Corp

Corporate presentation summary

28 Oct, 2026

Platform and market focus

  • Physical AI combines AI/ML experiment design, robotics, inline analytics, and closed-loop optimization for chemicals, pharmaceuticals, and critical minerals.

  • Self-driving labs integrate robotics, analytics, and machine learning to run continuous autonomous experiments; claimed efficiency gains include 40x energy, 4x time, and 6x space efficiency.

  • Intelligent automation is positioned to improve R&D throughput and quality amid cited global investments of $42B in chemicals R&D, $145B in pharma process R&D, and $2T in clean-energy R&D.

  • Management estimates AI-guided automation can accelerate pharma lab-to-market timelines by 10–50x and add 1–2 years of commercial monetization under patent.

Revenue model and products

  • Three revenue streams: contract R&D, IP licensing, and product sales, supported by a scientific team and industry relationships built over 30+ years.

  • DirectInject-LC automates chemical analysis; accessories, services, and software licenses create recurring revenue, with four additional products in the pipeline.

  • DirectInject-LC has been adopted by 15 of the top 20 pharmaceutical companies by revenue.

  • Global distribution agreement with Mettler-Toledo spans 100 countries; the presentation cites US$3.8B in 2023 annual sales for the distributor.

Self-driving labs and partnerships

  • Multi-year master collaborative research agreement with Pfizer, signed in July 2024, supports self-driving lab development; Pfizer purchased two platforms.

  • Platform workflows support hit screening, route narrowing, and process refinement using data-rich mapping of reaction conditions, kinetics, yield, and process sensitivity.

  • A Seoul installation and training in December 2025 served KPBMA, representing 300 pharmaceutical and biopharma member companies.

  • The partner network includes pharmaceutical, instrumentation, research, and clean-energy organizations, including Pfizer, Mettler-Toledo, Roche, Takeda, and Natural Resources Canada.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Telescope Innovations